UID:
almahu_9949747871402882
Format:
1 online resource (250 pages)
Edition:
1st ed.
ISBN:
9783031418044
Series Statement:
Public Health Ethics Analysis Series ; v.8
Note:
Intro -- Foreword -- Preface -- In Memoriam: Vasantha Muthuswamy -- Case Study Authors -- Case Keyword Overview -- Chapter 1 -- Case 1.1: A Study on the Telemonitoring of COVID-19 Patients at Home -- Case 1.2: Trial Unblinding Following Emergency Authorization of Vaccines -- Case 1.3: COVID-19 Controlled Human Infection Studies -- Case 1.4: Early-Stage Investigations into Infectious Diseases -- Chapter 2 -- Case 2.1: Should Death and Grieving During the Pandemic Be Studied? -- Case 2.2: Should Widespread Off-Label Use of Medication Influence Research Prioritisation? -- Case 2.3: Studying the Treatment of COVID-19 Patients with Traditional Medicine -- Case 2.4: Research Reprioritization During the COVID-19 Pandemic -- Case 2.5: Challenges with Continuing Cancer Research in a Publicly Funded Hospital -- Chapter 3 -- Case 3.1: Self-Experimentation in the Development of COVID-19 Vaccines -- Case 3.2: Research with Chlorine Dioxide in a Prison During the COVID-19 Pandemic -- Case 3.3: Evaluating the Role of the BCG Vaccine as a Prophylactic in Elderly Populations -- Case 3.4: Publication, Pre-publication and Retraction of Research: How a Pandemic Magnifies Concerns About Publication Ethics -- Case 3.5: Retracted Research: Impacts and Outcomes -- Chapter 4 -- Case 4.1: Use of Convalescent Plasma in Severely Ill COVID-19 Patients -- Case 4.2: COVID-19 Antibody-Testing Initiatives in a European Country -- Case 4.3: Competing Priorities Under Pressure: Government Collaboration with Academic Institutions -- Case 4.4: Vaccine Research or Rollout? -- Chapter 5 -- Case 5.1: Adapting Face-to-Face Interviews to Respect Infection Control Measures -- Case 5.2: A Community-Based Intervention for Indigenous Older Persons with Mild to Moderate Dementia -- Case 5.3: Suspending Participation in Research -- Case 5.4: Ethics and Adaptive Trials in the COVID-19 Pandemic.
,
Case 5.5: The Impact of New Scientific Evidence on On-going COVID-19 Studies -- Chapter 6 -- Case 6.1: Ethics Approval of a Multi-centre Study: To Expedite or Not? -- Case 6.2: Ethics Review of Multi-centre Trials: Challenges and Unforeseen Issues -- Case 6.3: The Importance of Effective Research Ethics Review -- Case 6.4: Research into the Use of Ozone for Treatment of Patients with COVID-19 -- Case 6.5: Reviewing the Use of Convalescent Plasma -- Case 6.6: A Phase III COVID-19 Vaccine Trial -- Case 6.7: Research on Teleconsultation -- Chapter 7 -- Case 7.1: A Multinational COVID-19 Symptom Checker Application -- Case 7.2: Issues of Consent and Privacy in Establishing a Pregnancy Outcomes Registry -- Case 7.3: Ethical Conduct and Review of Research -- Case 7.4: Informed Consent and Data Protection in the Context of Increased Use of Information and Communication Technologies -- Case 7.5: Research into COVID-19 and Cancer in Populous Low-Income Neighbourhoods -- Chapter 8 -- Case 8.1: Should Pregnant Women Be Included in COVID-19 Vaccine Trials? -- Case 8.2: Ethics and Research Policy in a Forensic Psychiatric Hospital -- Case 8.3: Studying the Impact of COVID-19 on Vulnerable Populations -- Case 8.4: Inclusion of Persons with Disabilities in COVID-19 Research -- Chapter 9 -- Case 9.1: Ethical Challenges Arising When Recruiting Adolescent Minors by Telephone -- Case 9.2: Quantitative and Qualitative Research into Attitudes Towards COVID-19 -- Case 9.3: Seeking Consent to Research Involving the Use of Convalescent Plasma from COVID-19 Donors in the Treatment of Cancer... -- Case 9.4: A Study Involving Minimally Invasive Tissue Sampling in Adults Who Died from COVID-19 -- Case 9.5: COVID-19 Clinical Trials: Placebo Group Participants and the Right to Access the Experimental Product -- Learning and Teaching Guide -- Cases -- Approaches to Using the Cases.
,
Case Selection and Session Design -- Engagement and Discussion -- References -- Acknowledgments -- Disclaimer -- Contents -- Editors and Contributors -- Abbreviations -- Chapter 1: Introduction: Research Ethics and Health Policy in Epidemics and Pandemics -- 1.1 Taking a Broader Approach to ``Research Ethics ́́-- 1.2 Thematic Approach -- 1.3 The Ethical Importance of Research for Real-Time Policy and for the Benefit of Future Generations -- 1.4 Emergencies as Radically Non-ideal Contexts for Research -- 1.5 Relationships Between Research and Practice -- 1.6 Modifying Health Policy in the Context of Uncertainty and Open-Endedness -- 1.7 The Impact of Policy Choices on the Ethical Acceptability of Research -- 1.8 The Responsibilities of Researchers Who Are Part of the Policy-Making Process -- 1.9 Concluding Remarks -- Case 1.1: A Study on the Telemonitoring of COVID-19 Patients at Home -- Research -- Surveillance -- Case 1.2: Trial Unblinding Following Emergency Authorization of Vaccines -- Case 1.3: COVID-19 Controlled Human Infection Studies -- Research Justification -- Research Risks -- Case 1.4: Early-Stage Investigations into Infectious Diseases -- References -- Chapter 2: Setting Research Priorities -- 2.1 Introduction -- 2.2 The Role of Research Prioritization in Epidemics -- 2.3 What Considerations Should Inform Research Prioritization? -- 2.4 Research Prioritization in Practice -- 2.5 Challenges in Research Priority Setting -- Case 2.1: Should Death and Grieving During the Pandemic Be Studied? -- Case 2.2: Should Widespread Off-Label Use of Medication Influence Research Prioritisation? -- Case 2.3: Studying the Treatment of COVID-19 Patients with Traditional Medicine -- Case 2.4: Research Reprioritization During the COVID-19 Pandemic -- Case 2.5: Challenges with Continuing Cancer Research in a Publicly Funded Hospital -- References.
,
Chapter 3: Research Quality and Dissemination -- 3.1 Introduction -- 3.2 Research Quality -- 3.3 Disseminating and Publishing Research -- 3.4 Conclusion -- Case 3.1: Self-Experimentation in the Development of COVID-19 Vaccines -- Case 3.2: Research with Chlorine Dioxide in a Prison During the COVID-19 Pandemic -- Case 3.3: Evaluating the Role of the BCG Vaccine as a Prophylactic in Elderly Populations -- Case 3.4: Publication, Pre-publication and Retraction of Research: How a Pandemic Magnifies Concerns About Publication Ethics -- Case 3.5: Retracted Research: Impacts and Outcomes -- References -- Chapter 4: Boundaries Between Research, Surveillance and Monitored Emergency Use -- 4.1 Introduction -- 4.2 The Research-Practice Distinction -- 4.3 Locating the Distinction in the Primary Aim -- 4.3.1 Experimentation -- 4.4 Should Non-research Activities Be Conducted as Research Instead? -- 4.5 Conclusion -- Case 4.1: Use of Convalescent Plasma in Severely Ill COVID-19 Patients -- Case 4.2: COVID-19 Antibody-Testing Initiatives in a European Country -- Case 4.3: Competing Priorities Under Pressure: Government Collaboration with Academic Institutions -- Case 4.4: Vaccine Research or Rollout? -- References -- Chapter 5: Adapting and Adaptive Research -- 5.1 Introduction -- 5.2 Adapting - Not Deviating From - Scientific and Ethical Standards for Research -- 5.3 Adaptive Clinical Trials -- 5.4 Adapting Research to Epidemic Contexts -- 5.5 Conclusion -- Case 5.1: Adapting Face-to-Face Interviews to Respect Infection Control Measures -- Case 5.2: A Community-Based Intervention for Indigenous Older Persons with Mild to Moderate Dementia -- Case 5.3: Suspending Participation in Research -- Case 5.4: Ethics and Adaptive Trials in the COVID-19 Pandemic -- Case 5.5: The Impact of New Scientific Evidence on On-going COVID-19 Studies -- References.
,
Chapter 6: Ethics Review Challenges -- 6.1 Introduction -- 6.2 Challenges in the Ethics Review Processes -- 6.3 Challenges in the Ethics Analysis of Health Emergency Research -- 6.3.1 Social and Scientific Value of Research -- 6.3.2 Consent Processes -- 6.3.3 Research in the Transition from Research to Rollout -- 6.3.4 Use of Unproven Intervention Outside Research Settings -- 6.4 Conclusions -- Case 6.1: Ethics Approval of a Multi-centre Study: To Expedite or Not? -- Case 6.2: Ethics Review of Multi-centre Trials: Challenges and Unforeseen Issues -- Case 6.3: The Importance of Effective Research Ethics Review -- Case 6.4: Research into the Use of Ozone for Treatment of Patients with COVID-19 -- Case 6.5: Reviewing the Use of Convalescent Plasma -- Case 6.6: A Phase III COVID-19 Vaccine Trial -- Case 6.7: Research on Teleconsultation -- References -- Chapter 7: Ethical Issues Associated with Managing and Sharing Individual-Level Health Data -- 7.1 Introduction -- 7.2 Respect for Persons and Communities -- 7.2.1 The Consent Process -- 7.2.2 Consent for Use of Data in the Future -- 7.2.3 Waiving Consent and the Opt-Out Approach -- 7.2.4 Privacy -- 7.2.5 Curation, De-identification and Anonymization -- 7.2.6 Use of Existing Datasets -- 7.3 Promoting Equity -- 7.4 Conclusion -- Case 7.1: A Multinational COVID-19 Symptom Checker Application -- Case 7.2: Issues of Consent and Privacy in Establishing a Pregnancy Outcomes Registry -- Case 7.3: Ethical Conduct and Review of Research -- Case 7.4: Informed Consent and Data Protection in the Context of Increased Use of Information and Communication Technologies -- Case 7.5: Research into COVID-19 and Cancer in Populous Low-Income Neighbourhoods -- References -- Chapter 8: Dimensions of Vulnerability -- 8.1 Introduction -- 8.2 Conceptualizations of Vulnerability.
,
8.3 Vulnerability and Inclusion in Research Ethics.
Additional Edition:
Print version: Bull, Susan Research Ethics in Epidemics and Pandemics: a Casebook Cham : Springer International Publishing AG,c2024 ISBN 9783031418037
Language:
English
Keywords:
Electronic books.
;
Electronic books.
URL:
Click here to view book
URL:
Volltext
(kostenfrei)
URL:
Volltext
(kostenfrei)
